HER2-Targeted Therapies Summit

The HER2-Targeted Therapies Summit is dedicated to HER2 as a Pan-Tumor Target.

The HER2-Targeted Therapies Summit covers topics such as:

• Highlighting HER2 Pathology & Making the Link With Therapeutic Responsiveness
• Reflecting on a Two Decade Legacy of HER2-Targeted Therapy Data
• Harnessing Cutting Edge Blood Brain Barrier Penetrable Drugs to Tackle Cancer Metastases in the Brain From HER2 Positive Primary Tumors
• Breadth of Next Era HER2-Targeted Therapies in Development (By Drug Class) That Are Overcoming Resistance Challenges
• HER2-Targeted Therapies for HER2 Negative or HER2 Low Cancers
• HER2 Heterogeneity in Diseases Beyond Breast Cancer to Identify Treatment Opportunities
• New Frontiers for HER2-Targeted Therapies in Niche HER2 Expressing Cancers

The HER2-Targeted Therapies Summit will be held on 23-24 Jun 2021.